date founded

General

About Company
NEOVII Biotech is a globally active biotechnology company specializing in effective antibody therapies.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2003

Number of employees

Company Type

For Profit

IPO status

Private

Description

With development locations in Germany and the US, Neovii Biotech, founded in 2003, focuses on the development and commercialization of biotherapeutic products within a global network. Their biopharmaceutical products offer polyclonal antibody immunosuppressive therapy, catering to transplantation medicine and treatment options for hemato-oncological and immune disorders. Neovii Biotech's innovative therapies provide clients with life-transforming solutions.
Contacts
Similar Companies
999
PCI Biotech Holding ASA

PCI Biotech Holding ASA

PCI Biotech is a biopharmaceutical company focused on cancer treatment therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Oslo, Norway
Biogenera

Biogenera

BIOGENERA SpA is a biotechnology pharmaceutical company that develops patient-specific medicines for serious illnesses.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Bologna, Metropolitan City of Bologna, Italy

total rounds

5

total raised

$8.75M
Biopharm

Biopharm

Biopharm is a biotechnology company with over 28 years of experience in regenerative medicine.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Eppelheim, Germany
Clover Biopharmaceuticals

Clover Biopharmaceuticals

Clover Biopharmaceuticals is a clinical-stage biotech company focused on developing vaccines and biologic therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Biopharma

Location

Chengdu, Sichuan, China

total rounds

5

total raised

$343.65M

Financials

Co-Investors

Activity

Recent News
0